risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
- RxCUI
- 2166137
- RxNorm name
- risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
- Display name
- risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
- Full name
- risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7148c8eb-b39e-e20a-6494-a6df82392858 | {2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe) } Pack [GPCK] · risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack [PSN] · {2 (risankizumab-rzaa 75 MG per 0.83 ML Prefilled Syringe) } Pack [SY] | 3 | 173 | These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2019 | 20260319 |